Search research articles
Contact Us
Filters
Showing results (481-490 of 547) with videos related to
Page
of 55
Sort By:
Internal Medicine (Tokyo, Japan)
|
March 22, 2021
Gender Differences in the Circadian and Seasonal Variations in Patients with Takotsubo Syndrome: A Multicenter Registry at Eight University Hospitals in East Japan
Michiko Yoshizawa, Tomonori Itoh, Yoshihiro Morino, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
February 10, 2017
Impact of Acute Kidney Injury on In-Hospital Outcomes of Patients With Acute Myocardial Infarction - Results From the Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) Substudy
Shotaro Kuji, Masami Kosuge, Kazuo Kimura, et al.
The Journal of Invasive Cardiology
|
December 8, 2009
Preprocedural inflammation does not affect neointimal hyperplasia following everolimus-eluting stent implantation
Daisaku Nakatani, Junya Ako, Masao Yamasaki, et al.
Journal of Cardiology
|
April 20, 2021
Ischemic/bleeding event after short dual-antiplatelet therapy in patients with high bleeding risk: Sub-analysis of the MODEL U-SES study
Hirofumi Hioki, Ken Kozuma, Yoshihisa Kinoshita, et al.
The European Respiratory Journal
|
November 26, 2021
Selexipag for the treatment of chronic thromboembolic pulmonary hypertension
Takeshi Ogo, Hiroto Shimokawahara, Hideyuki Kinoshita, et al.
Cardiovascular Diabetology
|
April 6, 2016
Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial
Atsushi Tanaka, Teruo Inoue, Masafumi Kitakaze, et al.
ESC Heart Failure
|
February 24, 2023
The interaction between physical frailty and prognostic impact of heart failure medication in elderly patients
Takuro Abe, Kentaro Jujo, Daichi Maeda, et al.
Circulation Reports
|
March 11, 2021
Risk Factors of In-Hospital Lethal Arrhythmia Following Acute Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention - Insight From the J-MINUET Study
Jun Oikawa, Hidehira Fukaya, Junya Ako, et al.
International Journal of Cardiology
|
February 13, 2018
The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation
Hiroaki Shimokawa, Takeshi Yamashita, Shinichiro Uchiyama, et al.
The Tohoku Journal of Experimental Medicine
|
December 2, 2016
Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation
Takanori Ikeda, Hirotsugu Atarashi, Hiroshi Inoue, et al.
Page
of 55
Search research articles
Search
Showing results (481-490 of 547) with videos related to
Sort By:
Page
of 55
Internal Medicine (Tokyo, Japan)
|
March 22, 2021
Gender Differences in the Circadian and Seasonal Variations in Patients with Takotsubo Syndrome: A Multicenter Registry at Eight University Hospitals in East Japan
Michiko Yoshizawa, Tomonori Itoh, Yoshihiro Morino, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
February 10, 2017
Impact of Acute Kidney Injury on In-Hospital Outcomes of Patients With Acute Myocardial Infarction - Results From the Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) Substudy
Shotaro Kuji, Masami Kosuge, Kazuo Kimura, et al.
The Journal of Invasive Cardiology
|
December 8, 2009
Preprocedural inflammation does not affect neointimal hyperplasia following everolimus-eluting stent implantation
Daisaku Nakatani, Junya Ako, Masao Yamasaki, et al.
Journal of Cardiology
|
April 20, 2021
Ischemic/bleeding event after short dual-antiplatelet therapy in patients with high bleeding risk: Sub-analysis of the MODEL U-SES study
Hirofumi Hioki, Ken Kozuma, Yoshihisa Kinoshita, et al.
The European Respiratory Journal
|
November 26, 2021
Selexipag for the treatment of chronic thromboembolic pulmonary hypertension
Takeshi Ogo, Hiroto Shimokawahara, Hideyuki Kinoshita, et al.
Cardiovascular Diabetology
|
April 6, 2016
Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial
Atsushi Tanaka, Teruo Inoue, Masafumi Kitakaze, et al.
ESC Heart Failure
|
February 24, 2023
The interaction between physical frailty and prognostic impact of heart failure medication in elderly patients
Takuro Abe, Kentaro Jujo, Daichi Maeda, et al.
Circulation Reports
|
March 11, 2021
Risk Factors of In-Hospital Lethal Arrhythmia Following Acute Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention - Insight From the J-MINUET Study
Jun Oikawa, Hidehira Fukaya, Junya Ako, et al.
International Journal of Cardiology
|
February 13, 2018
The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation
Hiroaki Shimokawa, Takeshi Yamashita, Shinichiro Uchiyama, et al.
The Tohoku Journal of Experimental Medicine
|
December 2, 2016
Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation
Takanori Ikeda, Hirotsugu Atarashi, Hiroshi Inoue, et al.
Page
of 55